Publication | Closed Access

Taraxerol as a possible therapeutic agent on memory impairments and Alzheimer’s disease: Effects against scopolamine and streptozotocin-induced cognitive dysfunctions

Neurodegenerative DiseasesAlzheimer's DiseaseMedicineMemory ImpairmentsPsychopharmacologyPossible Therapeutic AgentNeuropharmacologySocial SciencesNeuroprotectionNeurologyNeurosciencePharmacotherapyStreptozotocin-induced Cognitive DysfunctionsPharmacologyNeurochemistryTreatment